Advanced search
Publication Cover
Cancer Biology & Therapy Volume 18, 2017 - Issue 6
Submit an article Journal homepage
642
Views
10
CrossRef citations to date
0
Altmetric
Research Paper

miR-337 can be a key negative regulator in melanoma

Wanan XiaoDepartment of Orthopedic Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, P.R. ChinaCorrespondence[email protected]
,
Enyang YaoDepartment of Orthopedic Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, P.R. China
,
Wei ZhengDepartment of Orthopedic Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, P.R. China
,
Feng TianDepartment of Orthopedic Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, P.R. China
&
Lijie TianDepartment of Orthopedic Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, P.R. China
Pages 392-399 | Received 21 Dec 2016, Accepted 23 Apr 2017, Published online: 16 Jun 2017

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Liang Xia, Linlin Wu, Hailong Xia, Jing Bao, Qingsheng Li, Xiaowen Chen & Ruixiang Xia. (2019) miR-337 suppresses cutaneous T-cell lymphoma via the STAT3 pathway. Cell Cycle 18:14, pages 1635-1645.
Read now

Articles from other publishers (9)

Xiaoding Xu, Chuwei Yu, Hongxiu He, Xiangyu Pan, Aijun Hou, Jianxun Feng, Rongrong Tan, Likun Gong, Jing Chen & Jin Ren. (2023) MiR-337-3p improves metabolic-associated fatty liver disease through regulation of glycolipid metabolism. iScience 26:11, pages 108352.
Crossref
Giuseppe Valacchi, Erika Pambianchi, Simona Coco, Alessandra Pulliero & Alberto Izzotti. (2022) MicroRNA Alterations Induced in Human Skin by Diesel Fumes, Ozone, and UV Radiation. Journal of Personalized Medicine 12:2, pages 176.
Crossref
Yinhua Pan, Yingzhu Zhao, Li Lihui, Yujie Xie & Quanqing Zou. (2021) MiR-337-3p suppresses migration and invasion of breast cancer cells by downregulating ESRP1. Acta Histochemica 123:7, pages 151777.
Crossref
Jin Shi, Qingliang Su, Fei Han, Wenping Chen, Donghua Zhang & Baoli Xu. (2021) MiR-337 suppresses pancreatic cancer development via STAT3/Wnt/β-catenin axis. Anti-Cancer Drugs 32:7, pages 681-692.
Crossref
Soudeh Ghafouri-Fard, Mahdi Gholipour & Mohammad Taheri. (2021) MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets. Frontiers in Oncology 11.
Crossref
Zahra Sadat Razavi, Vida Tajiknia, Shahab Majidi, Maryam Ghandali, Hamid Reza Mirzaei, Neda Rahimian, Michael R. Hamblin & Hamed Mirzaei. (2021) Gynecologic cancers and non-coding RNAs: Epigenetic regulators with emerging roles. Critical Reviews in Oncology/Hematology 157, pages 103192.
Crossref
Yanbo Ma, Jincheng Duan & Xiuyan Hao. (2020) Down‐regulated HDAC3 elevates microRNA‐495‐3p to restrain epithelial‐mesenchymal transition and oncogenicity of melanoma cells via reducing TRAF5. Journal of Cellular and Molecular Medicine 24:22, pages 12933-12944.
Crossref
Zhen Zhang, Luoyan Zhang, Bin Wang, Ran Wei, Yunxia Wang, Jipeng Wan, Chi Zhang, Lin Zhao, Xiaoxiao Zhu, Yunhong Zhang, Chu Chu, Qiang Guo, Xunqiang Yin & Xia Li. (2020) MiR-337–3p suppresses proliferation of epithelial ovarian cancer by targeting PIK3CA and PIK3CB. Cancer Letters 469, pages 54-67.
Crossref
Mengyao Sun, Xiaona Ma, Chen Tu, Xiaopeng Wang, Jianqiang Qu, Shuang Wang & Shengxiang Xiao. (2019) MicroRNA‐378 regulates epithelial–mesenchymal transition and metastasis of melanoma by inhibiting FOXN3 expression through the Wnt/β‐catenin pathway. Cell Biology International 43:10, pages 1113-1124.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.